Pipeline

Before we create
we listen

Serving multiple
patient needs

Everything we do is driven by patients and what they have to live with. We innovate and refine solutions that can be integrated in a seamless way into patients’ lives.

Program
Pre clinical
Phase 1
Phase 2
Phase 3

CLE-400
Potent a2-adrenergic
(and SST4, and H4)
receptors agonist

CLE-500
SPG block

1

CLE-100 MDD

Developing a new treatment for patients suffering from Major Depressive Disorder

More Info
2

CLE-400 Chronic Itch

Developing a novel topical drug to alleviate neuropathic itch

More Info
3

CLE-400 Neuropathic Pain

Developing a novel non-opioid topical product to alleviate Peripheral neuropathic pain

More Info
4

CLE-500 Cluster Headaches

Developing a new treatment to alleviate Cluster Headaches

More Info
5

CLE-600 Parkinson’s disease

Developing a novel treatment for Parkinson’s disease patients, for better nights and better mornings

More Info
6

OLAR®

Continuous drug delivery to the stomach and upper GI tract

More Info
Skip to content